VirtuleAP
Virtuleap develops VR-based cognitive training (Enhance VR) and assessment (Cogniclear VR) platforms serving healthcare providers, pharmaceutical companies, research institutions, and consumers. Founded in 2018 and headquartered in Lisbon, the company combines neuroscience with immersive VR for cognitive health and early-decline detection.
- Company typePrivate
- Founded2018
- HeadquartersLaunceston, United Kingdom
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What VirtuleAP does
Virtuleap is a Lisbon-headquartered, UK-registered (Virtuleap LDA) digital health company founded in 2018 that develops virtual-reality-based cognitive training and assessment platforms, with approximately 20 employees and $4.1M in disclosed funding to date. Its two core products are Enhance VR, a gamified brain-training application spanning seven cognitive categories (memory, attention, problem-solving, processing speed, cognitive flexibility, motor control, spatial orientation) and distributed via the Meta Quest store for consumers; and Cogniclear VR, a self-paced multidomain cognitive assessment tool featuring 14 exercises across 8 cognitive categories designed for clinical research and early detection of cognitive decline. The underlying technology collects dense behavioral and sensor telemetry (headset/controller movement, hand- and eye-tracking, spatial position) during VR sessions, enabling examiner-independent automatic scoring and the discovery of digital biomarkers — collected at approximately 80,000 data points per 3-minute assessment.
The company monetizes through a multi-stream revenue model: enterprise software subscriptions (quote-based annual licensing for healthcare providers and research institutions), direct consumer purchases on the Meta Quest store, clinical research services delivered to pharmaceutical and academic partners, and pharma partnership studies for cognitive monitoring. Its go-to-market blends product-led consumer acquisition via the Meta Quest store, enterprise direct sales with Request-a-Demo and Enterprise Login portals, event-driven demand generation (e.g., Web Summit 2024), and a formal distributor program — most notably a strategic channel partnership with Fortis Healthcare for India. Customer and partner concentration spans Roche (dementia, through the Lusíadas Saúde clinical protocol), UCLA (chemotherapy-related cognitive research), Vall d'Hebron (VIRCODE study in Type-2-diabetes-linked MCI), UCSF/VA (alcohol-use-disorder Volition VR), Penumbra (OEM integration into Real i-series headsets), Fortis Healthcare, HP, Pacific Brain Health Center, and the National Innovation Centre Ageing, across the UK, Portugal, Spain, the US, and India. Regulatory and evidence work includes the EU-funded VR Health Champions consortium (€338K to Virtuleap, Oct 2024–Sep 2027) for regulatory strategy and market entry, and multiple peer-reviewed publications across Frontiers in Digital Health, Frontiers in Virtual Reality, MDPI Applied Sciences, and CEUR workshop proceedings.
VirtuleAP firmographics
Firmographics- Name
- VirtuleAP
- Legal name
- Virtuleap LDA
- Website
- https://virtuleap.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Virtuleap develops VR-based cognitive training (Enhance VR) and assessment (Cogniclear VR) platforms serving healthcare providers, pharmaceutical companies, research institutions, and consumers. Founded in 2018 and headquartered in Lisbon, the company combines neuroscience with immersive VR for cognitive health and early-decline detection.
- Ownership category
- akta.pro rank
VirtuleAP industry classification
Industry- Product category
- Cognitive Health VR Software
- NAICS
- All Other Amusement and Recreation Industries (71399)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
- akta.pro primary industry
- VR/AR/XR Game Studios (MPAFAAAE)
- akta.pro secondary industries
- VR-Based Skills Training Simulations (Soft Skills, Customer Service, Leadership) (EDAFAJAA), AR/VR & Immersive Learning Content Development (EDAGAKAI), VR/XR Hardware & Accessories (Headsets, Controllers, Trackers, Haptics) (MPAFAGAG)
Keywords
Where VirtuleAP is headquartered
LocationHeadquarters
- HQ city
- Launceston
- HQ country
- United Kingdom
- HQ region
- Europe
Offices2 records
Markets served
VirtuleAP business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Enterprise Software Licenses: Enterprise solutions for healthcare providers, pharma companies, and research institutions with administrative tools, remote control features, and survey capabilities
- Consumer VR App Sales: Direct-to-consumer VR gaming app available through Meta Quest store for individual brain training
- Clinical Research Services: Research partnerships with pharma and healthcare institutions for clinical trials using VR cognitive assessment and training tools
- Pharma Partnership Studies: Pilot programs with pharmaceutical companies like Roche for cognitive monitoring in clinical settings
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise licensing with administrative tools and clinical study capabilities |
Go-to-market motion5 records
Distribution channels4 records
Marketing channels6 records
VirtuleAP product offering
Product offeringCore offering
Virtuleap develops and sells immersive virtual reality (VR) software products for cognitive health. Its flagship offerings are Enhance VR, a gamified brain training application with exercises spanning seven cognitive categories, and Cogniclear VR, a self-paced multidomain cognitive assessment tool consisting of 14 exercises across 8 cognitive domains designed for clinical studies and early detection of cognitive decline.
Product overview
Virtuleap offers two core products: Enhance VR (cognitive training platform) and Cogniclear VR (cognitive assessment tool). Enhance VR provides gamified cognitive workouts via a library of VR games targeting memory, attention, processing speed, problem-solving, motor control, cognitive flexibility, and spatial orientation. Cogniclear VR serves as the complementary assessment layer — a self-paced, examiner-independent cognitive evaluation tool that collects detailed behavioral and gameplay data across 8 cognitive domains to detect early cognitive decline. The two products share a common VR infrastructure, enterprise management tools (Remote Control, Survey Engine), and are backed by the same research pipeline.
Differentiator
Problem solved
Functional benefit
Brands
- Enhance VR: A growing library of VR brain training games designed with neuroscientists to test and train cognitive functions such as memory, attention, problem-solving, and motor control.
- Cogniclear VR
Products and services
- Enhance VR An immersive brain training app offering short, gamified cognitive workouts across seven categories (spatial orientation, memory, attention, flexibility, problem solving, processing, motor control). Available directly to consumers through the Meta Quest store and to enterprises for clinical deployment and rehabilitation.
- Cogniclear VR A self-paced cognitive assessment tool integrated into VR that provides multidomain evaluation through 14 short exercises across 8 cognitive categories. Designed for clinical studies, pharmaceutical trials, and early detection of cognitive impairment, with examiner-independent automatic scoring and detailed behavioral data capture.
Quantifiable outcome
- 629 users providing feedback on Cogniclear VR product
- +1 more outcomes
Companies that use VirtuleAP
Customer profileNamed customers12 records
Segments5 records
Ideal customer profiles4 records
VirtuleAP technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature8 records
VirtuleAP partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered flagship and core.
- Instituto Pedro NunesflagshipProject coordinator for VR Health Champions consortium consisting of 18 partners from 8 EU member states.
- EIT Health InnoStarsflagshipCo-coordinator of VR Health Champions project supporting healthcare VR/AR applications.
- Lusíadas SaúdecorePartnership under Roche's Building Tomorrow Together - Innovation in Dementia initiative to develop and refine Cogniclear VR through continuous cycles of end-user testing and iterative development.
- Fortis HealthcarecoreStrategic partnership to deploy Enhance VR and Cogniclear across Fortis Healthcare facilities in India, one of the world's largest healthcare markets.
- Universitat Internacional de CatalunyacoreStudy exploring Enhance VR's potential for improving emotional regulation in children and adolescents, examining cognitive training's protective effect against anxiety and depression. Funded by Brain & Behavior Research Foundation.
- RochecoreVirtuleap selected as one of four companies to pilot VR-based cognitive assessment and training platform as part of Roche's 'Building Together Tomorrow' program to promote solutions for people with dementia. Clinical protocol implemented by Lusíadas hospital group.
- Vall d'Hebron Research Institute (VHIR)coreVIRCODE project - prospective randomized pilot study evaluating Enhance VR effectiveness in delaying cognitive decline in Mild Cognitive Impairment patients with Type 2 diabetes. Funded by LaCaixa Foundation.
- PenumbracorePartnership to support Enhance VR cognitive training games in Penumbra's Real i-series Headsets offering engaging immersive experiences to care providers and mental health professionals.
- UCSF / VAcorePartnership to develop Volition VR game for individuals with Alcohol Use Disorder, based on Cognitive Bias Modification paradigm to change automatic thought patterns contributing to maladaptive behaviors.
- UCLAcoreUCLA researchers using Enhance VR games to monitor cognition in chemotherapy patients. Study compares VR game results with traditional neuropsychological tests to understand chemotherapy's cognitive impact.
Scale indicators11 records
Recent moves6 records
Expansion highlights6 records
VirtuleAP competitors and assessment
Company assessmentDirect peers
- XRHealth: XRHealth runs a VR telehealth platform for cognitive, neurological, and mental health therapy delivered through FDA-registered VR headsets, with similar enterprise sales motion to clinics and hospital networks. Competitor in clinical VR for cognition and rehabilitation.
- Akili Interactive: Akili develops FDA-cleared digital therapeutics (EndeavorRx for ADHD, early-stage cognition) for cognitive health. Both companies sell prescription-grade and consumer VR/digital products targeting attention, memory, and processing speed, with overlapping healthcare provider and pharma customers.
- Cambridge Cognition: Cambridge Cognition provides the CANTAB cognitive assessment battery and digital health tools sold into pharma CNS trials and clinical research organizations. Direct competitor on the assessment side of Cogniclear, particularly for clinical trial endpoints.
- Cognivue: Cognivue is an FDA-cleared computerized cognitive assessment device marketed to primary care and specialty clinics for early detection of cognitive impairment. Direct competitor on the clinical cognitive assessment workflow for healthcare providers.
- Posit Science (BrainHQ): Posit Science operates BrainHQ, a directly competing computerized cognitive training platform with peer-reviewed efficacy across memory, attention, and processing speed. Comparable core proposition (science-backed cognitive training plus assessment) and similar healthcare/senior-living customer base.
Broad incumbents
- MindMaze: MindMaze is a well-funded neuro-recovery platform combining VR, motion capture, and AI for stroke, traumatic brain injury, and cognitive rehabilitation. Overlapping VR-based cognitive rehabilitation use case and customer base of hospitals and rehabilitation centers, but at much larger scale and broader portfolio.
Emerging players
- AppliedVR: AppliedVR develops FDA-authorized EaseVRx for chronic pain and is expanding into broader VR therapeutics including cognition and mental health. Direct overlap as a competitor in regulated VR therapeutic products sold to providers and payers.
- BehaVR: BehaVR builds VR-based digital therapeutics for mental health (anxiety, chronic pain, stress), with pharma and payer distribution. Overlapping use cases in cognitive and mental wellness VR delivered through health plan and provider channels.
- SyncThink: SyncThink uses VR/eye-tracking for clinical concussion and cognitive assessment (FDA-cleared EYE-SYNC). Comparable technology approach (VR-based cognitive assessment with strong sports medicine and clinical deployment focus) and overlapping research/pharma customers.
Others
- Penumbra (Real Immersive): Penumbra's Real Immersive division (and partner for Virtuleap's Enhance VR) sells Healthcare-grade VR headsets (Real i-series) bundled with cognitive and wellness content into rehab and senior care facilities. Partner and adjacent hardware/content distributor for Virtuleap.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
VirtuleAP social profiles
Digital presenceVirtuleAP financial estimates
Financial estimateRevenue estimate
Valuation estimate
VirtuleAP leadership team
Management profileNumber of profiles
Profiles2 records
VirtuleAP funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
VirtuleAP M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about VirtuleAP
What does VirtuleAP do?
Virtuleap develops and sells immersive virtual reality (VR) software products for cognitive health. Its flagship offerings are Enhance VR, a gamified brain training application with exercises spanning seven cognitive categories, and Cogniclear VR, a self-paced multidomain cognitive assessment tool consisting of 14 exercises across 8 cognitive domains designed for clinical studies and early detection of cognitive decline.
Is VirtuleAP a public or private company?
VirtuleAP is a private company. It is classified as venture growth investor backed and is currently operating.
When was VirtuleAP founded?
VirtuleAP was founded in 2018. It employs 11 to 50 people.
Where is VirtuleAP based?
VirtuleAP is headquartered in Launceston, United Kingdom, in the Europe region.
How does VirtuleAP make money?
Four revenue lines are on record. Enterprise Software Licenses are the primary driver. The others are consumer VR App Sales, clinical Research Services and pharma Partnership Studies.
Who are VirtuleAP's main competitors?
Direct peers on record are XRHealth, Akili Interactive, Cambridge Cognition, Cognivue and Posit Science (BrainHQ). MindMaze is listed as a broad incumbent. Emerging players are AppliedVR, BehaVR and SyncThink. Penumbra (Real Immersive) is listed as an others.
Does VirtuleAP have an API?
No public API is recorded for VirtuleAP.
What industry is VirtuleAP in?
VirtuleAP's product category is Cognitive Health VR Software. Its primary akta.pro industry code is MPAFAAAE, VR/AR/XR Game Studios, with a secondary code of EDAFAJAA, VR-Based Skills Training Simulations (Soft Skills, Customer Service, Leadership). Its NAICS code is 71399 and its SIC code is 7372.